OPRD1 and colitis: In contrast, i.p. injection of the peripheral δ opioid YNT-2715, which cannot pass through the blood-brain barrier, reduced the pathology of colitis, suggesting that the DOR agonists ameliorate colitis without modulating the CNS (Figure 7 top).